Chronic Bronchitis Clinical Trials

A listing of Chronic Bronchitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
RejuvenAir System Trial for COPD With Chronic Bronchitis

terms of disease burden and third in terms of mortality. Chronic bronchitis (CB) is a common clinical phenotype within the umbrella of a COPD diagnosis and is classically defined as chronic cough and

pneumonia
bronchodilator
pulmonary function tests
obstruction
cough
  • 25 views
  • 16 Jun, 2021
  • 20 locations
VX-770 for the Treatment of Chronic Bronchitis

This research study will test how well a new drug affects bronchiectasis or chronic bronchitis. The new drug, Ivacaftor (KALYDECO), is a drug that has recently been approved by the U.S. Food and

bronchodilator
diabetes
cardiac arrhythmia
vx-770
pulmonary disease
  • 1 views
  • 23 Jan, 2021
  • 1 location
Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

effectiveness of Bronchial Rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis. A total of 270 patients will be randomized at up

  • 0 views
  • 24 Apr, 2021
  • 1 location
VISN 23 Chronic Obstructive Pulmonary Disease (COPD) Case Management Using Home Telehealth Equipment

). The patients in this group would be those patients who traditionally suffer from emphysema, and/or chronic bronchitis.

bronchitis
severe chronic obstructive pulmonary disease
emphysema
  • 64 views
  • 07 Nov, 2020
  • 2 locations
Roflumilast in Non-CF Bronchiectasis Study (2019)

to noxious environmental agents (e.g. tobacco smoke) that affects both the airways (chronic bronchitis) and lung parenchyma (emphysema), leading to loss of lung function and exercise capacity. Both

  • 0 views
  • 10 May, 2021
  • 1 location
Woodsmoke Particulate + Prednisone

Deployment of military personnel has been associated with increased respiratory illness likely due, in part, to inhalation of unusual particulate matter (PM), such as from burn pits. Inflammation is a key initial response to inhaled particulates. The researchers have developed a protocol using inhaled wood smoke particles (WSP) as a …

  • 0 views
  • 16 Jun, 2021
  • 1 location
A Phase II Randomized Double-blind Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Chronic Obstructive Pulmonary Disease and Chronic Bonchitis.

  • 0 views
  • 12 May, 2021
  • 93 locations
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

A multi-center, randomized, 36-month, parallel- group, non-inferiority, phase III study to compare the effectiveness of roflumilast (Daliresp, 500 mcg quaque die (QD) or alternate regimen) therapy versus azithromycin (250 mg QD, 500 mg QD three times per week, or alternate regimen) to prevent hospitalization or death in a patients at …

pulmonary disease
muscarinic antagonist
azithromycin
COPD
daliresp
  • 54 views
  • 10 Apr, 2021
  • 33 locations
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients

The purpose of this study is to support the dose selection for future studies by evaluating efficacy and safety of different QBW251 doses in COPD patients with chronic bronchitis and a history

bronchitis
  • 176 views
  • 16 Jun, 2021
  • 174 locations
HHHFA in COPD Patients With Chronic Bronchitis

Heated, humidified high-flow air (HHHFA) devices improve airway clearance. HHHFA use for an average of 1.6 hours a day in COPD patients with chronic bronchitis improves health-related quality of

  • 0 views
  • 08 Apr, 2021
  • 1 location